If you have already registered, please check your email for the webinar link.

Event Overview

The solid tumor microenvironment (TME) poses many challenges for the immune system. Altered signaling pathways and metabolic constraints in combination with persistent antigen loads cause T-cell exhaustion, which in turn leads to tumor progression. Various strategies are currently in use and unde development to recover T-cell functionality in the TME. Using small-molecule blockades to enhance T-cell functionality is one avenue that researchers are exploring alongside other advanced adoptive cell therapies. To predict a patient’s response to a therapy and to optimize individual therapies, immune-cell profiling systems can be utilized for polyfunctional analysis. In this webinar brought to you by The Scientist, presented by IsoPlexis, strategies to improve T-cell function in the TME will be explored, and IsoPlexis’ Polyfunctional Strength Index (PSI) will be explained in relation to a range of TME immunotherapy challenges.

Topics to be Covered
  • Improving T-cell functionality for adoptive T-cell therapy in metastatic colon cancer, using small-molecule strategies
  • Applying polyfunction to a range of solid tumor microenvironment challenges in immunotherapy
Thursday, April 11, 2019
2:30 - 4:00 PM, Eastern Time


Sruthi Ravindranathan
Sruthi Ravindranathan, PhD
Post Doctoral Researcher, Waller Lab
Winship Cancer Institute of Emory University

Jon Chen, MS
Jon Chen, MS
Director of New Collaborations


Register Now

Improving T-cell Function in the Solid Tumor Microenvironment using Advanced Immunotherapeutic Strategies

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.